Royal Bank of Canada
PMN icon

Royal Bank of Canada’s ProMIS Neurosciences PMN Stock Holding History

Royal Bank of Canada’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4K Buy
268
+50
+23% +$745 ﹤0.01% 6512
2025
Q4 		$1K Sell
218
-1
-0.5% -$10 ﹤0.01% 7031
2025
Q3 		$2K Hold
219
– – ﹤0.01% 6904
2025
Q2 		$3K Hold
219
– – ﹤0.01% 6752
2025
Q1 		$4K Hold
219
– – ﹤0.01% 6421
2024
Q4 		$5K Buy
219
+189
+630% +$4.71K ﹤0.01% 6547
2024
Q3 		$1K Buy
30
+1
+3% +$37 ﹤0.01% 6735
2024
Q2 		$1K Hold
29
– – ﹤0.01% 6878
2024
Q1 		$1K Hold
29
– – ﹤0.01% 6842
2023
Q4 		$1K Hold
29
– – ﹤0.01% 6965
2023
Q3 		$1K Sell
29
-71
-71% -$4.62K ﹤0.01% 6927
2023
Q2 		$10K Buy
100
+12
+14% +$1.59K ﹤0.01% 6482
2023
Q1 		$10K Sell
88
-2
-2% -$246 ﹤0.01% 6321
2022
Q4 		$10K Buy
90
+43
+91% +$6.01K ﹤0.01% 6548
2022
Q3 		$7K Buy
+47
New +$6.92K ﹤0.01% 6605

Other funds holding PMN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM

Royal Bank of Canada's PMN Position: Q1 2026 in Review

Royal Bank of Canada increased its ProMIS Neurosciences (PMN) stake by 23% in Q1 2026, buying an estimated $745 and bringing the position to 268 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #6512.

Royal Bank of Canada first reported a position in PMN in Q3 2022 and has held it in 15 quarters since. The position peaked at $10K in Q2 2023. 25 funds tracked by Wall St. Rank hold PMN as of Q1 2026.

  • Royal Bank of Canada held 268 shares of ProMIS Neurosciences worth $4K as of Q1 2026.
  • Royal Bank of Canada bought 50 ProMIS Neurosciences shares in Q1 2026, an estimated $745.
  • ProMIS Neurosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6512 holding.
  • Royal Bank of Canada first reported a position in ProMIS Neurosciences in Q3 2022 and has held it in 15 quarters since.
  • Royal Bank of Canada's ProMIS Neurosciences position peaked at $10K in Q2 2023.
  • 25 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.